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Endovascular treatment thirty-three after the first pub-
lished report on angioplasty, continues to be a rapidly
evolving field for the treatment of patients with periph-
eral arterial disease. A multitude of studies detailing
technical improvements and innovative developments
have been published. The morphology of a lesion may
have an influence on the technical outcome, results at
follow up and also risk of treatment.
The TASC (TransAtlantic Inter-Society Consensus)
document introduced a classification system that cate-
gorised lesions with regard to their accessibility to either
percutaneus treatment or surgery. It categorised lesions
into four types with: type A lesions ideal for endovascu-
lar approach; type B lesions where endovascular
approach is still the preferred technique; type C lesions
where surgical approach is preferred and type D lesions
where surgery is the option of choice.
Today, endovascular practice, percutaneous translum-
inal angioplasty (PTA) with or without stenting, is used
far more frequently for all types of lower extremity
occlusive lesions, reflecting the continuing advances in
imaging techniques, angioplasty equipment, and endo-
vascular expertise.
The role of endovascular intervention, PTA/ stenting,
in the treatment of peripheral arterial disease is also
expanding, and its promise of limb salvage and symp-
tom relief with reduced morbidity and mortality makes
an attractive alternative to surgery and, as most endo-
vascular interventions are performed on brief hospitali-
zations, hospital costs are cut considerably. Compared
with open surgical procedures, endovascular interven-
tions offer comparable or superior long-term rates of
success.
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